SPORTS MEDICINE

WEREWOLF◊ FLOW 90◊ COBLATION◊ Wand

Featuring FLOW-IQ◊ technology, backed by 20 years of experience, legacy and innovation
Part of our 10-year dedication to continuous improvement and impact in sports medicine.

Hero 1_COB18_Flow90_Tip_Top_14288.png

The future in your hands

Shown to have a significantly faster ablation rate than other frequently used 90-degree arthroscopy wands.***6

The FLOW 90 Wand features an innovative tip design to help surgeons manipulate tissue easier. Combined with WEREWOLF◊ Technology, it's a must-have in the OR.

  • FLOW~IQ◊ Technology changes the size and intensity of the plasma field based on desired tissue effects to address various shoulder pathologies
  • SCOPE-SENSING◊ Technology on the WEREWOLF Controller provides a higher level of protection for expensive surgical equipment*1
  • Integrated suction tubing eliminates the cost associated with a separate suction tubing line
  • Versatility and surgeon-driven tip design

Use of COBLATION wands has been shown to result in better economic outcomes.**2-5

Hero 2_COB18_Flow90_Tubing_14277.png


Product Features

10 years of FLOW Wands​

he origin of FLOW Wands was inspired by a simple but important need: to allow surgeons more control and access across different joint indications and tissue types when using COBLATION Technology. ​

Adapting to growing needs and expectations in arthroscopic surgery, painstaking research and development was dedicated to refine both our wand design and performance. ​

Introducing distinct improvements in our wand geometry, electrode design and outflow control, the FLOW 50◊ Wand and FLOW 90◊ Wand harnessed FLOW~IQ◊ Technology to enhance the standard of ablation across multiple joint soft tissues. ​

FLOW Wands represent the tactile expression of COBLATION technology’s core promise of control and performance…and there’s more to come.​ ​

Hero_1_COB18_WEREWOLF_Controller_LowFront_Flow90Connected_14266 (1).jpg


Reference Materials

Medical education



Related Products



Disclaimers

*Compared to QuantumTM 2. Demonstrated in vitro.

**In Germany, Spain, United Kingdom and United States, compared to mechanical debridement.

***As demonstrated in vitro when tested at default settings; p<0.05.

Citations
  1. Smith+Nephew 2019. Internal report. P/N 106506-01 Rev.A.
  2. Adeyami A, et al. Value in Health. 2018;21:S168.
  3. Adeyami A, et al. International Conferance on Osteoprosis, Osteoarthritis and Musculuoskeletal Diseases; May 25 - 26, 2017; London, United Kingdom.
  4. Adeyemi A, et al. Value in Health. 2017;20:A584.
  5. Adeyami A, et al. ISPOR 20th Annual European Congress; 4 Nov - 8 Nov, 2017; Glasgow, Scotland, UK.
  6. Smith+Nephew 2020. Internal report. P/N 112090 Rev.A
  7. ArthroCare Corporation 2015. Internal report. P/N 65200-01 Rev.A.
  8. Smith+Nephew 2019. Internal report. P/N 88079-01 Rev.C.

Title

Text

Explore